Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 159 (LINC00159) is a human gene that encodes a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs that play roles in fine-tuning gene expression, chromatin remodeling, genome architecture, and transcription regulation. LINC00159 is transcribed but does not encode a protein. While lincRNAs as a class are increasingly recognized for their tissue-specific roles in regulating neighboring gene expression and participating in diverse cellular processes, the specific molecular functions and disease associations of LINC00159 remain poorly characterized in the current scientific literature. It is not considered a conventional therapeutic target (such as a receptor or enzyme) and is not directly linked to known drugs, clinical biomarkers, or established disease processes.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 159 (LINC00159).